MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-10-2025
Myomo Operating Income 2011-2025 | MYO
Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.
FormulaOperating profit = Revenue – Operating expensesFeatures of the metric
- Evaluates business efficiency
Shows how well the company controls its production and administrative costs. - Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies. - Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.
If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.
Annual Operating Income Myomo
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -10.7 M | -10.3 M | -10.5 M | -10.8 M | -10.5 M | -6.55 M | -3.28 M | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -3.28 M | -10.8 M | -8.94 M |
Quarterly Operating Income Myomo
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -3.52 M | -4.59 M | -3.52 M | - | -958 K | -1.12 M | -3.89 M | - | -2.02 M | -1.1 M | -2.67 M | - | -2.82 M | -2.9 M | -2.74 M | - | -2.03 M | -2.6 M | -2.93 M | - | -2.55 M | -2.85 M | -3.42 M | - | -2.83 M | -2.71 M | -2.68 M | - | -2.71 M | -2.68 M | -2.4 M | - | -1.43 M | -1.93 M | -1.36 M | - | -934 K | -689 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -689 K | -4.59 M | -2.43 M |
Operating Income of other stocks in the Medical devices industry
| Issuer | Operating Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Abiomed
ABMD
|
230 M | - | - | $ 17.2 B |  USA |
 |
Acutus Medical
AFIB
|
-11.7 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
-1.27 M | - | 3.58 % | $ 2.21 M | USA |
 |
Apyx Medical Corporation
APYX
|
-17.3 M | $ 3.47 | -3.61 % | $ 120 M | USA |
 |
Boston Scientific Corporation
BSX
|
2.6 B | $ 95.88 | -0.23 % | $ 141 B | USA |
 |
Cognyte Software Ltd.
CGNT
|
-5.13 M | $ 9.44 | -1.1 % | $ 678 M |  Israel |
 |
Bio-Rad Laboratories
BIO
|
269 M | $ 301.88 | 0.04 % | $ 8.52 B | USA |
 |
Apollo Endosurgery
APEN
|
-31.4 M | - | - | $ 475 M | USA |
 |
Conformis
CFMS
|
-46.3 M | - | - | $ 16.4 M | USA |
 |
Eargo
EAR
|
-112 M | - | - | $ 10.2 M | USA |
 |
BioSig Technologies
BSGM
|
-12.9 M | - | 37.08 % | $ 85.7 M | USA |
 |
Cardiovascular Systems
CSII
|
-35.8 M | - | 0.15 % | $ 844 M | USA |
 |
Bruker Corporation
BRKR
|
253 M | $ 47.67 | -0.94 % | $ 7.1 K | USA |
 |
Cutera
CUTR
|
-156 M | - | -10.19 % | $ 1.99 M | USA |
 |
Abbott Laboratories
ABT
|
6.82 B | $ 124.51 | -0.27 % | $ 217 B | USA |
 |
InMode Ltd.
INMD
|
113 M | $ 14.55 | 0.55 % | $ 1.15 B | Israel |
 |
EDAP TMS S.A.
EDAP
|
-20.5 M | $ 3.39 | 14.2 % | $ 126 M |  France |
 |
LivaNova PLC
LIVN
|
129 M | $ 62.83 | -0.4 % | $ 3.41 B |  Britain |
|
LENSAR
LNSR
|
-10.7 M | $ 12.0 | -0.09 % | $ 138 M | USA |
 |
Neovasc
NVCN
|
-31.1 M | - | - | $ 111 M |  Canada |
 |
Orthofix Medical
OFIX
|
-84.6 M | $ 15.09 | -0.46 % | $ 575 M |  Curacao |
 |
Dynatronics Corporation
DYNT
|
-2.45 M | - | 14.99 % | $ 929 K | USA |
 |
PAVmed
PAVM
|
-68.8 M | $ 0.28 | -0.9 % | $ 2.02 M | USA |
 |
IRIDEX Corporation
IRIX
|
-10 M | $ 1.2 | 5.47 % | $ 19.4 M | USA |
 |
Second Sight Medical Products
EYES
|
-24.7 M | - | -0.97 % | $ 54.4 M | USA |
 |
Quanterix Corporation
QTRX
|
-49.7 M | $ 6.48 | -2.11 % | $ 244 M | USA |
 |
Align Technology
ALGN
|
608 M | $ 157.08 | -0.48 % | $ 11.8 B | USA |
 |
NanoVibronix
NAOV
|
-3.58 M | - | - | $ 1.08 M | USA |
 |
Accuray Incorporated
ARAY
|
7.84 M | $ 0.82 | -4.19 % | $ 84.3 M | USA |
 |
IRadimed Corporation
IRMD
|
22 M | $ 97.63 | 0.59 % | $ 1.24 B | USA |
 |
Avinger
AVGR
|
-16.6 M | - | -20.74 % | $ 369 K | USA |
 |
ClearPoint Neuro
CLPT
|
-19.7 M | $ 14.03 | -3.17 % | $ 379 M | USA |
 |
FONAR Corporation
FONR
|
5.31 M | $ 14.47 | -0.41 % | $ 94.8 M | USA |
 |
AxoGen
AXGN
|
-3.29 M | $ 32.21 | -1.32 % | $ 1.43 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
-64.9 M | - | - | $ 3.31 B | USA |
 |
Sintx Technologies
SINT
|
-13.4 M | $ 3.6 | 1.69 % | $ 13.5 M | USA |
 |
GBS
GBS
|
-10.6 M | - | -0.57 % | $ 7.12 M | USA |
 |
CONMED Corporation
CNMD
|
200 M | $ 40.21 | 0.42 % | $ 1.24 B | USA |
 |
Sensus Healthcare
SRTS
|
8.09 M | $ 3.82 | 0.68 % | $ 62.3 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-35 M | $ 17.22 | -1.09 % | $ 397 M | USA |